Related references
Note: Only part of the references are listed.Histopathologic tumor regression grading in patients with gastric carcinoma submitted to neoadjuvant treatment: results of a Delphi survey
Andrianos Tsekrekos et al.
HUMAN PATHOLOGY (2019)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches
Michael Davidson et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
Perioperative chemotherapy for resectable gastric cancer - what is the evidence?
Erling A. Bringeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Neoadjuvant treatment of locally advanced esophageal and junctional cancer: the evidence-base, current key questions and clinical trials
Claire L. Donohoe et al.
JOURNAL OF THORACIC DISEASE (2017)
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET ONCOLOGY (2016)
Location of Lymph Node Involvement in Patients with Esophageal Adenocarcinoma Predicts Survival
Aaldert K. Talsma et al.
WORLD JOURNAL OF SURGERY (2014)
Complete pathological response after neoadjuvant treatment in locally advanced esophageal cancer predicts long term survival: A retrospective cohort study
Farrukh Hassan Rizvi et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Classification of Pathologic Response to Neoadjuvant Therapy in Esophageal and Junctional Cancer Assessment of Existing Measures and Proposal of a Novel 3-Point Standard
Claire L. Donohoe et al.
ANNALS OF SURGERY (2013)
Which is the Optimal Response Criteria for Evaluating Preoperative Treatment in Esophageal Cancer: RECIST or Histology?
Yukinori Kurokawa et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery
Karen Becker et al.
ANNALS OF SURGERY (2012)
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
Surya S. A. Y. Biere et al.
LANCET (2012)
Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution
Carlo Castoro et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
Jurjen J. Boonstra et al.
BMC CANCER (2011)
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
Bryan H. Burmeister et al.
EUROPEAN JOURNAL OF CANCER (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal Cancer
Kenneth L. Meredith et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Prognostic Relevance of Skip Metastases in Esophageal Cancer
Klaus L. Prenzel et al.
ANNALS OF THORACIC SURGERY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
INITIAL STAGE AFFECTS SURVIVAL EVEN AFTER COMPLETE PATHOLOGIC REMISSION IS ACHIEVED IN LOCALLY ADVANCED ESOPHAGEAL CANCER: ANALYSIS OF 70 PATIENTS WITH PATHOLOGIC MAJOR RESPONSE AFTER PREOPERATIVE CHEMORADIOTHERAPY
Min Kyoung Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus
Jessica M. Leers et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Total number of resected lymph nodes predicts survival in esophageal cancer
Nasser K. Altorki et al.
ANNALS OF SURGERY (2008)
Refining esophageal cancer staging after neoadjuvant therapy: Importance of treatment response
Andrew P. Barbour et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical impact of lymphadenectomy extent in resectable esophageal cancer
Roderich E. Schwarz et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
Val Gebski et al.
LANCET ONCOLOGY (2007)
Lymphatic spread and microinvolvement in adenocarcinorna of the esophago-gastric junction
Paulus G. Schurr et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma
JL Hornick et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer - implications for response classification
PM Schneider et al.
ANNALS OF SURGERY (2005)
Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
R Ryan et al.
HISTOPATHOLOGY (2005)
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
LR Chirieac et al.
CANCER (2005)
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: Degree of pathologic response and not clinical parameters dictated patient outcome
JA Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tumor response to induction chemoradiation: influence on survival after esophagectomy
JS Donington et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2003)
Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy:: Histomorphologic analysis
W Schröder et al.
WORLD JOURNAL OF SURGERY (2002)
Share Paper
